CENNTRO INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS
(Unaudited)
| ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Introductory Note
Except as otherwise indicated by the context, references in this Quarterly Report on Form 10-Q (this “Form 10-Q”) to the “Company,” “Cenntro,” “we,” “us” or “our” are references to the combined
business Cenntro Inc. and its subsidiaries. The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) summarizes the significant factors affecting our results of operations, liquidity, capital
resources and contractual obligations. The following discussion and analysis should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and related notes included elsewhere herein.
A. Key Components of Results of Operations
Net revenues
Up until the three months ended March 31, 2024, we generate revenue primarily through the sale of ECVs to our channel partners. Starting in 2022, especially after the
acquisition of CAE and the termination of the channel partners in North America, we have started to transform our go-to-market model to Cenntro Branded EV Centers globally.
Net revenues during the three months ended 2024 and 2023 were generated from (a) vehicles sales, which primarily represent net revenues from sales of Metro® vehicles (including
vehicle kits), Logistar™ 200, Logistar™ 260, Logistar™ 400, Avantier™, Logistar™ 100 and Clubcar, (b) sales of ECV spare-parts related to our Metro® vehicles, and (c) other sales, which primarily were: (i) the sales of inventory of outsourced ECV
batteries and (ii) charges on services provided to channel partners for technical developments and assistance with vehicle homologation or certification.
Cost of goods sold
Cost of goods sold mainly consists of production-related costs including costs of raw materials, consumables, direct labor, overhead costs, depreciation of plants and equipment,
manufacturing waste treatment processing fees and inventory write-downs. We incur cost of goods sold in relation to (i) vehicle sales and spare-part sales, including, among others, purchases of raw materials, labor costs, and manufacturing
expenses that related to ECVs, and (ii) other sales, including cost and expenses that are not related to ECV sales.
Cost of goods sold also includes inventory write-downs. Inventories are stated at the lower of cost or net realizable value. The cost of raw materials is determined on the basis
of weighted average. The cost of finished goods is determined on the basis of weighted average and is comprised of direct materials, direct labor cost and an appropriate proportion of overhead. Net realizable value is based on estimated selling
prices fewer selling expenses and any further costs of completion. Adjustments to reduce the cost of inventory to net realizable value are made, if required, for estimated excess, obsolescence, or impaired balances. Write-downs are recorded in
the cost of goods sold in our statements of operations and comprehensive loss.
Operating expenses
Our operating expenses consist of general and administrative, selling and marketing expenses, and research and development expenses. General and administrative expenses are the
most significant components of our operating expenses. Operating expenses also include provision for doubtful accounts and impairment loss for long-lived assets.
Research and Development Expenses
Research and development expenses consist primarily of employee compensation and related expenses, prototype expenses, costs associated with assets acquired for research and
development, product development costs, production inspection and testing expenses, product strategic advisory fees, third-party engineering and contractor support costs and allocated overhead. We expect our research and development expenses to
increase as we continue to invest in new ECV models, new materials and techniques, vehicle management and control systems, digital control capabilities and other technologies.
Selling and Marketing Expense
Selling and marketing expenses consist primarily of employee compensation and related expenses, sales commissions, marketing programs, freight costs, travel and entertainment
expenses and allocated overhead. Marketing programs consist of advertising, tradeshows, events, corporate communications and brand-building activities. We anticipate that our selling and marketing expenses will not increase as we shift our
strategy towards strengthening our existing market developments in 2024, instead of pursuing the rapid expansions undertaken in 2023.
General and Administrative Expenses
General and administrative expenses consist primarily of employee compensation and related expenses for administrative functions including finance, legal, human resources, and
fees for third-party professional services. While we continue to monitor general and administrative expenses, we anticipate that our general and administrative expenses will not increase in 2024 as we committed to improve operational efficiency
in the next two years, following rapid expansions in previous years.
Accounts receivable and provision for doubtful accounts
The Company adopted ASC 326 Financial Instruments – Credit Losses using the modified retrospective approach through a cumulative-effect adjustment to accumulated deficit from
January 1. 2023 and interim periods therein. Management used an expected credit loss model for the impairment of accounts receivable as of period ends. Management believes the aging of accounts receivable is a reasonable parameter to estimate
expected credit loss, and determines expected credit losses for accounts receivables using an aging schedule as of period ends. The expected credit loss rates under each aging schedule were developed on basis of the average historical loss rates
from previous years, and adjusted to reflect the effects of those differences in current conditions and forecasted changes. Management measured the expected credit losses of accounts receivable on a collective basis. When an accounts receivable
does not share risk characteristics with other accounts receivables, management will evaluate such accounts receivable for expected credit loss on an individual basis. Doubtful accounts balances are written off and deducted from allowance. when
receivables are deemed uncollectible. after all collection efforts have been exhausted and the potential for recovery is considered remote.
Impairment loss for long-lived assets
We evaluate the recoverability of long-lived assets or asset group with determinable useful lives whenever events or changes in circumstances indicate that an asset or a group
of assets’ carrying amount may not be recoverable. We measure the carrying amount of long-lived asset against the estimated undiscounted future cash flows expected to result from the use of the assets or asset group and their eventual
disposition. The carrying amount of the long-lived asset or asset group is not recoverable when the sum of the undiscounted expected future net cash flows is less than the carrying value of the asset being evaluated. Impairment loss is calculated
as the amount by which the carrying value of the asset exceeds its fair value. Fair value is generally determined by discounting the cash flows expected to be generated by the assets or asset group, when the market prices are not readily
available. The adjusted carrying amount of the assets become new cost basis and are depreciated over the assets’ remaining useful lives. Long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable
cash flows are largely independent of the cash flows of other assets and liabilities.
Other income (expenses)
Interest expense, net
Interest expense, net, consists of interest on outstanding loans and the convertible promissory notes.
Income(loss) from and impairment on equity method investments
Entities over which we have the ability to exercise significant influence but do not have a controlling interest through investment in common shares, or in-substance common
shares, are accounted for using the equity method. Under the equity method, we initially record our investment at cost and subsequently recognize our proportionate share of each such entity’s net income or loss after the date of investment into
the statements of operations and comprehensive loss and accordingly adjust the carrying amount of the investment. When our share of losses in the equity of such entity equals or exceeds our interest in the equity of such entity, we do not
recognize further losses, unless we have incurred obligations or made payments or guarantees on behalf of such entity. An impairment charge is recorded when the carrying amount of the investment exceeds its fair value and this condition is
determined to be other-than-temporary. The adjusted carrying amount of the assets become new cost basis.
Key Operating Metrics
We prepare and analyze operating and financial data to assess the performance of our business and allocate our resources. The following table sets forth our key performance
indicators for the three months ended March 31, 2024 and 2023.
| |
|
Three Months ended March 31,
|
|
| |
|
|
|
|
|
|
| |
|
(Unaudited)
|
|
|
Gross margin of vehicle sales
|
|
|
6.34
|
%
|
|
|
1.63
|
%
|
Gross margin of vehicle sales. Gross margin of vehicle sales is defined as gross profit of vehicle sales divided by total revenue of vehicle sales.
Results of Operations
The following table sets forth a summary of our statements of operations for the periods indicated:
| |
Three Months ended March 31,
|
| |
2024
|
2023
|
|
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|
Combined Statements of Operations Data:
|
|
|
|
Net revenues
|
3,391,999
|
3,470,544
|
|
Cost of goods sold
|
(3,377,728)
|
(3,275,800)
|
|
Gross profit
|
14,271
|
194,744
|
|
Operating Expenses:
|
|
|
|
Selling and marketing expenses
|
(1,316,763)
|
(1,868,985)
|
|
General and administrative expenses
|
(6,361,196)
|
(7,358,264)
|
|
Research and development expenses
|
(1,727,830)
|
(1,569,919)
|
|
Total operating expenses
|
(9,405,789)
|
(10,797,168)
|
| |
|
|
|
Loss from operations
|
(9,391,518)
|
(10,602,424)
|
| |
|
|
|
Other Income (Expense):
|
|
|
|
Interest expense, net
|
73,242
|
(54,415)
|
|
(Loss) Income from equity method investments
|
(13,520)
|
19,042
|
|
Other (expense) income, net
|
(168,574)
|
358,075
|
|
Loss on redemption of convertible promissory notes
|
—
|
(2,100)
|
|
Loss on exercise of warrants
|
—
|
(212,870)
|
|
Change in fair value of convertible promissory notes and derivative liability
|
(705)
|
(126,272)
|
|
Change in fair value of equity securities
|
234,887
|
653,016
|
|
Gain from cross-currency swaps
|
5,933
|
—
|
|
Impairment of Long-term investments
|
—
|
(1,146,128)
|
|
Loss before income taxes
|
(9,260,255)
|
(11,113,977)
|
|
Income tax expense
|
30,032
|
—
|
|
Net loss
|
(9,230,223)
|
(11,113,977)
|
|
Less: net loss attributable to non-controlling interests
|
(72)
|
(156,028)
|
|
Net loss attributable to shareholders of the Company
|
(9,230,151)
|
(10,957,949)
|
Comparison of the Three months ended March 31, 2024 and 2023
Net Revenues
The following table presents our net revenue components by amount and as a percentage of the total net revenues for the periods presented.
| |
|
Three Months Ended March 31,
|
|
| |
|
2024
|
|
|
2023
|
|
| |
|
Amount
|
|
|
%
|
|
|
Amount
|
|
|
%
|
|
|
(Expressed in U.S. Dollars)
|
|
(Unaudited)
|
|
|
Net revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vehicle Sales
|
|
$
|
2,514,777
|
|
|
|
74.2
|
%
|
|
$
|
2,840,963
|
|
|
|
81.9
|
%
|
|
Spare-part sales
|
|
|
828,785
|
|
|
|
24.4
|
%
|
|
|
598,036
|
|
|
|
17.2
|
%
|
|
Other sales
|
|
|
48,437
|
|
|
|
1.4
|
%
|
|
|
31,545
|
|
|
|
0.9
|
%
|
|
Total net revenues
|
|
$
|
3,391,999
|
|
|
|
100.0
|
%
|
|
$
|
3,470,544
|
|
|
|
100.0
|
%
|
Net revenues for the three months ended March 31, 2024 were approximately $3.4 million, a decrease of approximately $0.1 million or 2.3% from approximately $3.5 million for the
three months ended March 31, 2023. The decrease in net revenues in 2024 was primarily attributed to a decrease in vehicle sales by approximately $0.3 million due to the decrease of average selling price from approximately $22,000 to $15,000,
offset by an increase in spare-part sales by approximately $0.2 million.
Additional units were sold during the three months ended March 31, 2024; we sold 165 ECVs, including 29 fully assembled Metro® units, 8 fully assembled Logistar™ 200, 26 fully
assembled Logistar™ 100, 4 fully assembled Teemak™ , 42 fully assembled Logistar™ 260, 4 fully assembled Logistar™ 400 units, 29 fully assembled Avantier™ units, 20 Clubcar units and 3 Antric® V5 units compared with 129 ECVs for the three months
ended March 31, 2023, including 17 fully assembled Metro® units, 48 fully assembled Logistar™ 200, 39 fully assembled Logistar™ 100, 1 fully assembled Teemak™ and 24 fully assembled Logistar™ 260.
Geographically, the vast majority of our net revenues were generated from vehicle sales in the Europe during the three months ended March 31, 2024 and 2023. For the three months
ended March 31, 2024, net revenues from Europe, North America, and Asia as a percentage of total revenues was 49.0%, 18.5%, and 32.5%, respectively, compared to 88.2%, 0.9%, and 10.9%, respectively for the corresponding period in 2023.
For the three months ended March 31, 2024, net revenues from vehicle sales in Europe, North America, and Asia as a percentage of total vehicle net revenues was 61.8%, 24.9%, and
13.3%, respectively, compared to 93.8%, 1.1%, and 5.1%, respectively, for the corresponding period in 2023.
Cost of goods sold
The following table presents our cost of goods sold by amount and as a percentage of the total cost of goods sold for the periods presented.
| |
Three Months Ended March 31,
|
|
| |
2024
|
|
2023
|
|
| |
Amount
|
|
%
|
|
Amount
|
|
%
|
|
|
(Expressed in U.S. Dollars)
|
(Unaudited)
|
|
|
Cost of goods sold:
|
|
|
|
|
|
|
|
|
|
Vehicle Sales
|
$ (2,355,403
|
)
|
69.7
|
%
|
$ (2,794,762
|
)
|
85.3
|
%
|
|
Spare-part sales
|
(920,289
|
)
|
27.2
|
%
|
(464,224
|
)
|
14.2
|
%
|
|
Other sales
|
(102,036
|
)
|
3.1
|
%
|
(16,814
|
)
|
0.5
|
%
|
|
Total cost of goods sold
|
$ (3,377,728
|
)
|
100.00
|
%
|
$ (3,275,800
|
)
|
100.00
|
%
|
Cost of goods sold for the three months ended March 31, 2024 was approximately $3.4 million, an increase of approximately $0.1 million or approximately 3.1% from approximately
$3.3 million for the three months ended March 31, 2023. The increase of cost of vehicle sales was mainly caused by the increased cost of spare-parts sales and other sales of approximately $0.5 million and $0.09 million, respectively, offset by
the decreased cost of vehicle sales of approximately $0.4 million.
Gross Profit
Gross profit for the three months ended March 31, 2024 was approximately $0.01 million, a decrease of approximately $0.18 million from approximately $0.19 million of gross
profit for the three months ended March 31, 2023. For the three months ended March 31, 2024 and 2023, our overall gross margin was approximately 0.4% and 5.6%, respectively. Our gross margin of vehicle sales for the three months ended March 31,
2024 and 2023 was 6.34% and 1.63%, respectively. The decrease of our gross profit was caused by a decrease in the gross profit of spare-part sales and other sales of approximately $0.2 million and $0.07 million, respectively, offset by the
increase in the gross profit of vehicle sales of approximately $0.1 million.
Selling and Marketing Expenses
Selling and marketing expenses for the three months ended March 31, 2024 were approximately $1.3 million, a decrease of approximately $0.6 million or approximately 29.6% from
approximately $1.9 million for the three months ended March 31, 2023. The decrease in selling and marketing expenses in 2024 was primarily attributed to the decrease in marketing expenses, others, freight and selling employees’ share-based
compensations of approximately $0.3 million, $0.1 million, $0.2 million and $0.1 million, respectively, offset by the increase in service fees related to European market and distribution channel research of approximately $0.2 million.
General and Administrative Expenses
General and administrative expenses for the three months ended March 31, 2024 were approximately $6.4 million, a decrease of approximately $1.0 million or approximately 13.3%
from approximately $7.3 million for the three months ended March 31, 2023. The decrease in general and administrative expenses in 2024 was primarily attributed to a decrease in legal and professional fee, salary and social insurance and office
expenses of approximately $0.5 million, $0.2 million and $0.7 million, respectively, offset by the increase in ROU amortization of approximately $0.4 million.
Research and Development Expenses
Research and development expenses for the three months ended March 31, 2024 were approximately $1.7 million, an increase of approximately $0.2 million or approximately 10.1%
from approximately $1.6 million for the three months ended March 31, 2023. The increase in research and development expenses in 2024 was primarily attributed to the increase salary expense of approximately $0.3 million, offset by the decrease in
design and development expenses of approximately $0.1 million.
Interest income (expense), net
Interest income (expense), net, mainly consists of interest income from deposit. Net interest income was approximately $0.07 million for the three months ended March 31, 2024, a
change of approximately $0.12 million compared to the approximately $0.05 million in interest expense for the three months ended March 31, 2023. The increase was primarily attributable to (i) a decrease in interest expense to convertible bonds of
approximately $0.2 million, (ii) offset by the decrease in interest income of approximately $0.09 million from HWE.
Other expense (income), net
Other expense, net for the three months ended March 31, 2024 was approximately $0.17 million, representing a change of approximately $0.53 million compared to approximately
$0.36 million of other income, net for the three months ended March 31, 2023. The change of other income in 2024 compared to 2023 was primarily attributable to (i) a decrease of approximately $0.2 million in investment income from the wealth
management products purchased from banks during the first quarter in 2024 (ii) an increase of approximately $0.4 million in loss on foreign currency exchange.
Change in fair value of convertible promissory notes and derivative liability
A loss in the change in fair value of convertible promissory notes and derivative liability for the three months ended March 31, 2024 was approximately nil, representing a
decrease of approximately $0.1 million compared to approximately $0.1 million of a loss in the change in fair value of convertible promissory notes and derivative liability for the three months ended March 31, 2023.
Change in fair value of equity securities
A gain in the change in fair value of equity securities for the three months ended March 31, 2024 was approximately $0.2 million. The gain was attributed to a downward
adjustment of approximately $0.02 million due to the fair value change of our investment on participating shares in Micro Money Fund SPC with an original investment value of $5 million, offset by an upward adjustment of approximately $0.3 million
from our investment on partnership shares in MineOne Fix Income Investment I L.P with an original investment value of $25 million.
Non-GAAP Financial Measures
Adjusted EBITDA for the three months ended March 31, 2024 and 2023
In addition to our results determined in accordance with GAAP, we believe Adjusted EBITDA, a non-GAAP measure is useful in evaluating operational performance. We use Adjusted
EBITDA to evaluate ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors in assessing operating performance.
Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adjusted EBITDA is not a measurement of our
financial performance under GAAP and should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP. We define Adjusted EBITDA as net income (or net loss) before net interest expense,
income tax expense, depreciation and amortization as further adjusted to exclude the impact of stock-based compensation expense and other non-recurring expenses including expenses related to loss on redemption of convertible promissory notes,
loss on exercise of warrants, and change in fair value of convertible promissory notes and derivative liability.
We present Adjusted EBITDA because we consider it to be an important supplemental measure of our performance and believe it is frequently used by securities analysts, investors,
and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including this non-GAAP financial measure as a reasonable basis for comparing our
ongoing results of operations. Management uses Adjusted EBITDA:
|
• |
as a measurement of operating performance because it assists us in comparing the operating performance of our business on a consistent basis, as it removes the impact of items not directly resulting from our
core operations;
|
|
• |
for planning purposes, including the preparation of our internal annual operating budget and financial projections;
|
|
• |
to evaluate the performance and effectiveness of our operational strategies; and
|
|
• |
to evaluate our capacity to expand our business.
|
By providing this non-GAAP financial measure, together with the reconciliation, we believe we are enhancing investors’ understanding of our business and our results of operations, as well as assisting
investors in evaluating how well we are executing our strategic initiatives. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by our competitors
because not all companies and analysts calculate Adjusted EBITDA in the same manner. Adjusted EBITDA has limitations as an analytical tool, and should not be considered in isolation, or as an alternative to, or a substitute for net income or other
financial statement data presented in our financial statements as indicators of financial performance. Some of the limitations are:
|
• |
such measures do not reflect our cash expenditures;
|
|
• |
such measures do not reflect changes in, or cash requirements for, our working capital needs;
|
|
• |
although depreciation and amortization are recurring, non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash
requirements for such replacements; and
|
|
• |
the exclusion of stock-based compensation expense, which has been a significant recurring expense and will continue to constitute a significant recurring expense for the foreseeable future, as equity awards
are expected to continue to be an important component of our compensation strategy.
|
Due to these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by
relying primarily on our GAAP results and using these non-GAAP measures only supplementally. As noted in the table below, Adjusted EBITDA includes adjustments to exclude the impact of stock-based compensation expense and material infrequent items.
It is reasonable to expect that these items will occur in future periods. However, we believe these adjustments are appropriate because the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing
operations of our business and may complicate comparisons of our internal operating results and operating results of other companies over time. In addition, Adjusted EBITDA may include adjustments for other items that we do not expect to regularly
occur in future reporting periods. Each of the normal recurring adjustments and other adjustments described in this paragraph and in the reconciliation table below help management with a measure of our core operating performance over time by
removing items that are not related to day-to-day operations.
The following table reconciles Adjusted EBITDA to the most directly comparable GAAP financial performance measure, which is net loss:
| |
|
Three Months Ended March 31,
|
|
| |
|
2024
|
|
|
2023
|
|
|
(Expressed in U.S. Dollars)
|
|
(Unaudited)
|
|
|
Net loss
|
|
$
|
(9,230,223
|
)
|
|
$
|
(11,113,977
|
)
|
|
Interest (expense) income, net
|
|
|
(73,242
|
)
|
|
|
54,415
|
|
|
Income tax benefit
|
|
|
(30,032
|
)
|
|
|
—
|
|
|
Depreciation and amortization
|
|
|
490,540
|
|
|
|
330,632
|
|
|
Share-based compensation expense
|
|
|
906,327
|
|
|
|
1,153,808
|
|
|
Loss on redemption of convertible promissory notes
|
|
|
—
|
|
|
|
2,001
|
|
|
Loss on exercise of warrants
|
|
|
—
|
|
|
|
212,870
|
|
|
Change in fair value of convertible promissory notes and derivative liability
|
|
|
705
|
|
|
|
126,272
|
|
|
Adjusted EBITDA
|
|
$
|
(7,935,925
|
)
|
|
$
|
(9,233,979
|
)
|
B. Liquidity and Capital Resources
We have historically funded working capital and other capital requirements primarily through bank loans, equity financings and short-term loans. Also, the reverse
recapitalization we have completed at the end of December 2021 provided significant funding for the Company’s operations. Cash is required primarily to purchase raw materials, repay debts and pay salaries, office expenses and other operating
expenses.
As of March 31, 2024 we had approximately $20.3 million in cash and cash equivalents and approximately $4.6 million of accounts receivables as compared to approximately $91.8
million in cash and cash equivalents and $2.7 million in accounts receivable as of March 31, 2022. For the three months ended March 31, 2024 and 2023, net cash used in operating activities was approximately $8.9 million and $17.4 million,
respectively.
Short-Term Liquidity Requirements
We believe our cash and cash equivalents will be sufficient for us to continue to execute our business strategy over the twelve months period following the date of issuance of
our annual report. Our current business strategy for the next twelve months includes (i) the continued rollout of our new ECV models and green energy related products in North America and Europe, as applicable and (ii) the establishment and
development of local distribution channels in the United States and the European Union. Actual results could vary materially as a result of a number of factors, including:
|
• |
The costs of bringing our new facilities into operation;
|
|
• |
The timing and costs involved in rolling out new ECV models to market;
|
|
• |
Our ability to manage the costs of manufacturing our ECVs;
|
|
• |
The costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;
|
|
• |
Revenues received from sales of our ECVs;
|
|
• |
The costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;
|
|
• |
Our ability to collect future revenues; and
|
|
• |
Other risks discussed in the section titled “Risk Factors.”
|
For the twelve months from the date hereof, we also plan to continue implementing measures to increase revenues and control operating costs and expenses, implementing
comprehensive budget controls and operational assessments, implementing enhanced vendor review and selection processes as well as enhancing internal controls.
Long-Term Liquidity Requirements
In the long-term, we plan to regionalize the manufacturing and supply chain relating to certain components of our ECVs in the geographic markets in which our ECVs are sold. In
the long-term, through our supply chain development know-how, we intend to establish supply chain relationships in North America and the European Union to support anticipated manufacturing and assembly needs in these markets, thereby reducing the
time in transit and potentially other landed costs elements associated with importing our components and spare parts from China. Currently, the majority of our revenues is derived from the sale of ECVs by private label channel partners that
assemble our vehicle kits in their own facilities. As part of our growth strategy, we plan to expand our channel partner network, and local assembly facilities to regionalize our manufacturing and supply chains to better serve our global
customers especially to expand our after-sales-market services offerings.
We intend to further expand our technology through continued investment in research and development. Since inception in 2013 through March 31, 2024 we have spent over
approximately $91.7 million in research and development activities related to our operations. We plan to increase our research and development expenditure over the long term as we build on our technologies in vehicle development, driving control,
cloud-based platforms, and innovations for promoting sustainable energy.
For our long-term business plan, we plan to fund current and future planned operations mainly through cash on hand, cash flow from operations, lines of credit and additional
equity and debt financings to the extent available on commercially favorable terms.
Working Capital
As of March 31, 2024, our working capital was approximately $67.5 million, as compared to a working capital of approximately $75.6 million as of December 31, 2023. The
approximately $8.1 million decrease in working capital during 2024 was primarily due to (i) the decrease of cash and cash equivalents of approximately $9.1 million, offset by the increase in prepayment and other current assets of approximately
$0.9 million.
Cash Flow
| |
|
Three Months Ended March 31,
|
|
| |
|
2024
|
|
|
2023
|
|
|
(Expressed in U.S. Dollars)
|
|
(Unaudited)
|
|
|
Net cash used in operating activities
|
|
$
|
(8,864,876
|
)
|
|
$
|
(17,363,332
|
)
|
|
Net cash provided by (used in) investing activities
|
|
|
306,761
|
|
|
|
(5,493,759
|
)
|
|
Net cash used in financing activities
|
|
|
-
|
|
|
|
(39,583,321
|
)
|
|
Effect of exchange rate changes on cash
|
|
|
(429,029
|
)
|
|
|
283,806
|
|
|
Net decrease in cash, cash equivalents, and restricted cash
|
|
|
(8,987,144
|
)
|
|
|
(62,156,606
|
)
|
|
Cash and cash equivalents, and restricted cash at beginning of the period
|
|
|
29,571,897
|
|
|
|
154,096,801
|
|
|
Cash and cash equivalents, and restricted cash at end of the period
|
|
$
|
20,584,753
|
|
|
$
|
91,940,195
|
|
Operating Activities
Our net cash used in operating activities was approximately $8.9 million, $17.4 million for the three months ended March 31, 2024 and 2023, respectively.
Net cash used in operating activities for the three months ended March 31, 2024 was primarily attributable to (i) our net loss of approximately $9.2 million and adjusted for
non-cash items of approximately $3.0 million, which primarily consisted of net foreign currency exchange loss, share based compensation expense, depreciation and amortization and amortization of operating lease right-of-use asset of approximately
$0.6 million, $0.9 million, $0.5 million and $1.2 million, respectively, (ii) the increase in inventories, accrued expense and other current liabilities, deferred revenue and operating lease liabilities and of approximately $0.7 million,
$0.6million, $0.7 million and $1.3 million, respectively, (iii) decrease in accounts receivable of approximately $1.8 million.
Investing Activities
Net cash provided by investing activities was approximately $0.3 million for the three months ended March 31, 2024. Net cash provided by investing activities for the three months
ended March 31, 2024 was primarily attributable to proceeds from equity securities of approximately $0.6 million, offset by the cash in purchase of property, plant and equipment of approximately $0.3 million.
Financing Activities
Net cash provided by financing activities was nil for the three months ended March 31, 2024.
Contractual Obligations
In February 2021, we signed a non-cancellable operating lease agreement for warehouse and trial production use in Freehold, New Jersey (Willowbrook Road) of approximately 9,750
square feet. The lease period began in February 2021 and ends in January 2025. The annual base rent for this facility is $175,500 starting from February 2023. The lease rent fee will be adjusted upward by 3% annually afterwards. We signed the
first addendum to lease on December 7, 2022 and the renewal period is two years commencing on Feb. 1, 2023 and terminating on Jan. 31, 2025, the annual base rent for the first twelve months the period is $17,500 and the annual base rent for the
second twelve months the period is $180,765.
In June 2021, we signed two non-cancellable operating lease agreements for approximately 11,700 square feet and 3,767 square feet, respectively, of two floors of an office
building in Hangzhou, China. The lease period for each lease agreement began in June 2021 and ends in May 2025. Pursuant to each agreement, we paid the first six months of our rent obligations in June 2021 and thereafter will be obligated to make
rental payments in advance semi-annually. The total annual base rent under these two lease agreements is $170,617 for the term ending May 2022 and $186,866 for the term ending May 2023.
On December 4, 2021, we entered into an entrustment agreement with Cedar Europe GmbH, a company organized under the laws of Germany (“Cedar”) pursuant to which we entrusted Cedar
to, in Cedar’s name, obtain a lease agreement for facilities in Germany and operate such lease facility under Cedar’s name in exchange for the Cenntro’s responsibility for all expenditures and costs of the lease. On December 24, 2021, Cedar
entered into a lease agreement for an approximately 27,220 square feet facility in Dusseldorf, Germany, where we now house our European Operations Facility. The lease period began on January 1, 2022 and ends on December 31, 2024. Pursuant to such
lease agreement, the total annual base rent is€354,787 (or approximately $383,512) for the lease term. On 17 January 2023, Cedar transferred the lease to CEGE, effectively from 1 February, 2023..
On January 20, 2022, we entered into an operating lease agreement (the “Jacksonville Lease”), between CAC, as tenant, the Company, as guarantor, and JAX Industrial One, LTD., a
Florida limited liability company, as landlord, for a facility of approximately 100,000 square feet in Jacksonville, Florida. The lease period commenced on January 20, 2022 and ends 120 months following a five-month rent abatement period.
Pursuant to the Jacksonville Lease, minimum annual rent is approximately $695,000, $722,800, and $751,710, for the first three years, sequentially, and rising thereafter.
On March 22, 2023, we signed a non-cancellable operating lease agreement for approximately 26,579 square feet as a local plant in Colombia, the lease period began on May 1, 2023
and the lease term is two years. The rent is COP 46,796,001.49 (or approximately $10,344.77) per month and the value of the lease fee shall be readjusted in a proportion equal to the consumer price index (CPl) certified by DANE as of December 31
of the immediately preceding year, plus two (2) points.
On May 19, 2023, we completed the acquisition with Cenntro Elecautomotiv, S.L., our EVC in Spain. On April 3, 2023, Cenntro Elecautomotiv, S.L. signed a non-cancellable operating
lease agreement for approximately 1,765 square feet as a local office in Barcelona, Spain, the lease period began on April 3, 2023 and the lease term is five years. The monthly rent is €1,776 (or approximately $1,919.9) plus value-added tax with
a two-month rent abatement period. In addition, Cenntro Elecautomotiv, S.L. signed a non-cancellable operating lease agreement for approximately 3,471 square feet as a service center in Barcelona, Spain on August 9, 2022, the lease period began
on August 1, 2022 and the lease term is ten years. The annual rent is €36,000 (or approximately $38,916) and shall be readjusted depending on the changes of the consumer price index (CPl) determined by the National Bureau of Statistics and its
substitute institutions. Legal defense is €6,000 (or approximately $6,486).
On April 4, 2023, we signed a non-cancellable operating lease agreement for approximately 2,500 square feet in Freehold, New Jersey. The lease period commenced on July 17, 2023
and ends on July 31, 2025. The annual base rent for the first twelve months of the period is $33,525 and the annual base rent for the second twelve months of the period is $35,201.
On February 16, 2022, we signed a non-cancellable operating lease agreement for apartment 53D in the building at 555 Tenth Avenue, New York, NY 10018. The term is one year and one
month, beginning on March 5, 2022 and ending on April 4, 2023. The monthly rent is $5,750. On February 1, 2023, we signed a renewal lease agreement. The term of this lease is one year, beginning on April 5, 2023 and ending on April 4, 2024. The
monthly rent is $5,950.
On March 25, 2022, we completed the acquisition of TME, and change its name to Cenntro Automotive Europe GmbH ("CAE”). TME signed a non-cancellable operating lease agreement for
approximately 5,212 square meters in 2019, the lease period starts on July 1, 2019 and ends on June 30, 2024, the monthly rent is €18,891 (or approximately $20,468).
On December 29, 2022, we signed a non-cancellable operating lease agreement with BAL Freeway Associates, LLC for approximately 64,000 square feet as a facility. The lease period
commenced on April 1, 2023 and ends five years following a one-month rent abatement period. The base rent for the first year is $115,200 per month. The monthly rent for the following four years is $119,808, $124,600.32, $129,584.33 and
$134,767.71, respectively.
On December 15, 2022, we signed a non-cancellable operating lease agreement for approximately 41,160 square feet as a facility in Howell, New Jersey. The lease period began on
February 1, 2023 and ends five years, the first annual base rent is $493,920 and the annual increase is 3%.
On August 4, 2022, we signed a non-cancellable operating lease agreement in Mexico as a facility. For the first 12 months, the rentable area is 58,413 square feet. Starting on the
month 13 to month 18, the rentable area is 85,554 square feet, and as of month 19 of the Rent Commencement Date and for the remainder of the initial term, the rentable area is 112,694 square feet. The lease period commenced on January, 2023 and
ends 8.5 years. The monthly rent is $29,225.38 and the annual increase is the higher of a) the consumer price index, or b) 2.5%.
On December 8, 2022, we signed a non-cancellable operating lease agreement for approximately 10,656 square feet as a headquarters and service center in Dominica Republic. The
lease period commenced on February 15, 2023 and ends five years. The rent is $9,000 per month and the annual increase is 5%.
On July 28, 2022, we signed a non-cancellable operating lease agreement for approximately 12,000 square feet as an EV center in Jacksonville, Florida. The lease period began on
September 1, 2022 and ends on August 31, 2029, the first annual base rent is $150,000 and the annual increase is 4%.
On August 31, 2023, we completed the acquisition with Antric GmbH in Germany. On July 20, 2022, Antric signed a non-cancellable operating lease agreement for approximately 4,361
square feet in Bochum, Germany, the lease period ends on December 31, 2026. The monthly rent is €3,605.26 (or approximately $3,988.14). On September 1, 2022, the lease area increased to 7,326 square feet and the monthly rent increased to
€6,000.32 (or approximately $6,637.55). The additional deposit is €18,000.96 (or approximately $19,912.66). On January 20, 2023, Antric signed another non-cancellable operating lease agreement for approximately 252 square feet in Bochum, Germany,
the lease period starts on February 1, 2023 and ends on December 31, 2026. The monthly rent increased to €6,315.38 (or approximately $6,986.07). On March 27, 2023, Antric signed another non-cancellable operating lease agreement for approximately
2,949 square feet in Bochum, Germany, the lease period starts on April 1, 2023 and ends on December 31, 2026. The monthly rent increased to €8,597.80 (or approximately $9,510.89).
We have not entered into any off-balance sheet financial guarantees or other off-balance sheet commitments to guarantee the payment obligations of any third parties. We have not
entered into any derivative contracts that are indexed to our shares and classified as shareholders’ equity or that are not reflected in our Audited Financial Statements. Furthermore, we do not have any retained or contingent interest in assets
transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to
us or engages in leasing, hedging or product development services with us.
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with U.S. GAAP requires our management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated and combined financial statements, the reported amounts of revenue and expenses during the reporting period and the related disclosures in the
consolidated and combined financial statements and accompanying footnotes. Out of our significant accounting policies, which are described in “Note 2—Summary of Significant Accounting Policies” of our consolidated and combined financial
statements for the three months ended March 31, 2024, included elsewhere in this Quarter Report, certain accounting policies are deemed “critical,” as they require management’s highest degree of judgment, estimates and assumptions. While
management believes its judgments, estimates and assumptions are reasonable, they are based on information presently available and actual results may differ significantly from those estimates under different assumptions and conditions.
Basis of presentation
The accompanying consolidated balance sheet as of December 31, 2023, which has been derived from audited financial statements, and the unaudited condensed consolidated financial statements as of March
31, 2024 and for the three months ended March 31, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).
Certain information and disclosures, which are normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States
of America (“U.S. GAAP”), have been condensed or omitted pursuant to such rules and regulations. Management believes that the disclosures made are adequate to provide a fair presentation. The interim financial information should be read in
conjunction with the financial statements and the notes for the fiscal year ended December 31, 2023. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results for the full year or any future
periods.
The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include provision for doubtful accounts, lower of cost and net realizable
value of inventories, impairment losses for long-lived assets and investments, valuation allowance for deferred tax assets and fair value measurement for share-based compensation expense, convertible promissory notes and warrants. Changes in
facts and circumstances may result in revised estimates. The current economic environment has increased the degree of uncertainty inherent in those estimates and assumptions.
Recently issued accounting standards pronouncement
Except for the ASUs (“Accounting Standards Updates”) issued but not yet adopted disclosed in “Note 2 (ab) Recently issued accounting standards pronouncements” of the Company 2023
Form 10-K, there is no ASU issued by the FASB that is expected to have a material impact on the Company’s unaudited condensed consolidated results of operations or financial position.
Revenue recognition
The Company recognizes revenue when goods or services are transferred to customers in an amount that reflects the consideration which it expects to receive in exchange for those
goods or services. In determining when and how revenue is recognized from contracts with customers, the Company performs the following five-step analysis: (i) identification of a contract with the customer; (ii) determination of performance
obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.
The Company generates revenue primarily through sales of light-duty ECVs, sales of ECV parts, and sales of off-road electric vehicles. Revenue is recognized at a point in time
once the Company has determined that the customer has obtained control over the product. Revenue is recognized net of return allowance and any taxes collected from customers, which are subsequently remitted to governmental authorities.
Significant judgement is required to estimate return allowances. The Company reasonably estimate the possibility of return based on the historical experience, changes in judgments on these assumptions and estimates could materially impact the
amount of net revenues recognized.
Shipping and handling costs for product shipments occur prior to the customer obtaining control of the goods are accounted for as fulfilment costs rather than separate performance
obligations and recorded as sales and marketing expenses.
Timing of revenue recognition was once the Company has determined that the customer has obtained control over the product. Accounts receivable represent revenue recognized for the
amounts invoiced and/or prior to invoicing when the Company has satisfied its performance obligation and has an unconditional right to the payment.
Contract liabilities primarily represent the Company’s obligation to transfer additional goods or services to a customer for which the Company has received consideration. The
consideration received remains a contractual liability until goods or services have been provided to the customer. For the three months ended March 31, 2024 and 2023, the Company recognized $890,646 and $98,818 revenue that was included in
contractual liabilities as of December 31, 2023 and 2022, respectively.
| ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
As a smaller reporting company as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is not required to provide the information required by
this item.
| ITEM 4. |
CONTROLS AND PROCEDURES
|
Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Roles 12a-15(e) or 15d-15(e) under the Exchange Act) designed to ensure that information required to be disclosed by us in the reports
that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our
Chief Executive Officer (“CEO”) and acting Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and acting CFO, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024, as required by paragraph (b) of Rules
13a-15 or 15d-15 under the Exchange Act. Based on this evaluation, management concluded that the Company's disclosure controls and procedures was not effective as of March 31, 2024, due to material weaknesses in the Company’s internal control over
financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) that have been previously identified but continue to exist. See Part II, Item 9A of the 2023 Form 10-K for additional information.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the first quarter of fiscal 2024 that have materially affected, or are reasonably likely to materially
affect, the Company’s internal control over financial reporting.
Remediation
As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31,2023, we began implementing a remediation plan to address the material weakness
mentioned above. The weakness will not be considered remediated, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
PART II
| ITEM 1. |
LEGAL PROCEEDINGS
|
From time to time, we may be subject to various legal claims and proceedings that arise from the normal course of business activities, including, third party intellectual property infringement claims
against us in the form of letters and other forms of communication. Litigation or any other legal or administrative proceeding, regardless of the outcome, could result in substantial cost, diversion of our resources, including management’s time and
attention, and, depending on the nature of the claims, reputational harm. In addition, if any litigation results in an unfavorable outcome, there exists the possibility of a material adverse impact on our results of operations, prospects, cash
flows, financial position and brand. Please refer to the description as contained in “Item 8 Financial Statements and Supplementary Data” on page F-1 of our Annual Report and the information described below.
On March 25, 2022, Shengzhou Hengzhong Machinery Co., Ltd. (“Shengzhou”), an affiliate of Cenntro Automotive Corporation, filed a demand for arbitration against Tropos
Technologies, Inc. with the American Arbitration Association (“AAA”), asserting claims for breach of contract and unjust enrichment. Shengzhou is seeking payment of $1,126,640 (exclusive of interest, costs, and attorneys’ fees) for outstanding
invoices owed by Tropos Technologies, Inc. to Shengzhou. As of the date of this report, Tropos Technologies, Inc. has not yet formally responded to the demand. On February 16, 2023, AAA appointed an arbitrator and arbitrator and on April 25,2023,
Tropos Technologies, Inc. filed a motion to dismiss the arbitration demand. On May 23,2023, Shengzhou filed a response in opposition to the motion to dismiss the arbitration demand. A hearing on the motion to dismiss was held on November 7, 2023.
On January 29, 2024, the arbitrator issued his opinion and order denying Tropos Technologies, Inc.’s motion to dismiss.
On July 22, 2022, Xiongjian Chen (the “Plaintiff") filed a complaint against Cenntro Electric Group Limited (“CENN”), Cenntro Automotive Group Limited (“CAG”), Cenntro Enterprise
Limited (“CEL”) and Peter Z. Wang (“Wang,” together with CENN, CAG and CEL, the “Defendants”) in the United States District Court for the District of New Jersey. The complaint alleges eleven causes of action sounding in contract and tort against
the Defendants, all pertaining to stock options issued to Mr. Chen pursuant to his employment as Chief Operating Officer of CAG. With respect to the four contract claims, Plaintiff alleges breach of contract claims pertaining to an employment
agreement between Plaintiff and CAG and a purported letter agreement between Plaintiff and CEL. With respect to the seven tort claims, Plaintiff alleges claims regarding purported misrepresentations and promises made concerning the treatment of
Plaintiff’s stock options upon a corporate transaction, including claims for tortious interference, fraud, promissory estoppel, negligent misrepresentation, unjust enrichment and conversion. The complaint seeks, among other things, money damages
(including compensatory and consequential damages) in the amount of $19 million, plus interest, attorneys’ fees and expenses. Defendants moved to dismiss the complaint against all Defendants for failure to state a claim and for lack of personal
jurisdiction over defendants CAG and CEL. On April 30, 2023, the District Court dismissed the claims against CAG and CEL for lack of personal jurisdiction. In addition, the District Court dismissed all the claims against Wang and CENN without
prejudice and permitted the Plaintiff to amend his complaint within 30 days to address the deficiencies in his claims against Wang and CENN. On July 20, 2023, the Defendants filed a motion seeking the dismissal of that amended complaint. On July
20, 2023, the Defendants filed a motion seeking the dismissal of Plaintiff’s amended complaint. On September 22, 2023, the Plaintiff filed a motion to strike our motion to dismiss. The Defendants filed reply briefs to Plaintiff’s motion to strike
on November 9, 2023. On January 25, 2024, the Magistrate Judge entered an order granting Plaintiff’s Motion to Amend and denying our Motion to Strike as moot.
On February 6, 2023, Hangzhou Ronda Tech Co., Limited (“Ronda”), one of Cenntro’s wholly owned subsidiaries, Ronda commenced a lawsuit against Fujian Newlongma Automotive
Co., Ltd. (“Newlongma”), one of Ronda’s suppliers in the Hangzhou Yuhang District People's Court (the “Court”), under which Ronda pled for (i) the termination of the vehicle purchase orders that Ronda placed with Newlongma on February 26, 2022;
(ii) recovery of advance payments for total amount of approximately $438,702; and (iii) compensation for damages equal to approximately $453,290. The mediation date was set for March 3, 2023 and subsequently docketed on July 3, 2023. Since then,
Newlongma filed a jurisdictional objection, and the Court dismissed that jurisdictional objection. Subsequently Newlongma filed a counterclaim and the Court hosted an exchange of evidence between the parties on October 17, 2023. On March 5,
2024, the Court issued a judgment ruling: (1) Newlongma was to return advance payments plus 100% damages totaling $869,702; (2) Ronda was to pay for outstanding invoices totaling $583,813; and (3) that all agreements between the parties were to
be terminated, including the vehicle purchase orders which have not been fulfilled. Newlongma is dissatisfied with this third judgment and filed an appeal on March 21, 2024. We are preparing relevant defense materials for the court hearing
scheduled on May 21, 2024.
On April 10, 2024, CEGL filed a lawsuit against MHP Americas, Inc. (“MHP”) for breach under the Master Consulting Services Agreement and SAP S/4HANA SOW by failure to properly implement the SAP S/4HANA
globally as set forth in those contracts, and for breach of implied covenants of good faith and fair dealing, causing Cenntro to suffer significant damages; and demanded a jury trial on all issues which are triable. Under this claim, CEGL is
seeking for a remittance of $512,226 paid to date and a recission of the remaining contract with MHP. On April 30, 2024, MHP filed a Notice of Removal of this action from the Superior Court of New Jersey to the U.S. District Court for the District
of New Jersey.
You should carefully consider the risks discussed in the section entitled “Risk Factors” in the 2023 Form 10-K, which could materially affect our business, financial condition, or future results. The
risks described in the 2023 Form 10-K are not the only risks facing the company. Additional risks and uncertainties not currently known to us or that we do not currently deem material, may also materially adversely affect our business, results of
operations, cash flows, and financial position.
| ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
There have been no sales of unregistered equity securities that we have not previously disclosed in filings with the U.S. Securities and Exchange Commission.
| ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES
|
None.
| ITEM 4. |
MINE SAFETY DISCLOSURES
|
Not applicable.
| ITEM 5. |
OTHER INFORMATION
|
Trading Arrangements of Section 16 Reporting Persons.
During the quarter ended March 31, 2024, no person who is required to file reports pursuant to Section 16(a) of the Securities and Exchange Act of 1934, as amended, with respect
to holdings of, and transactions in, the Company’s common shares (i.e. directors and certain officers of the Company) maintained, adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1(c)
arrangement”, as those terms are defined in Section 229.408 of the regulations of the SEC.
EXHIBIT INDEX
|
Exhibit
No.
|
|
Description of Exhibit
|
|
|
|
Certification of Principal Executive Officer required by Rule 13a-14(a).
|
|
|
|
Certification of Principal Financial Officer required by Rule 13a-14(a).
|
|
|
|
Certification required by Section 1350 of Chapter 63 of Title 18 of the United States Code.
|
|
101.INS*
|
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH*
|
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL*
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF*
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB*
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE*
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104*
|
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CENNTRO INC.
|
Dated: May 15, 2024.
|
|
| |
|
| |
CENNTRO INC.
|
| |
|
|
| |
By:
|
/s/ Peter Z. Wang
|
| |
|
Peter Z. Wang
|
| |
|
Chief Executive Officer
|
| |
|
(Principal Executive Officer)
|
| |
By:
|
/s/ Edward Ye
|
| |
|
Edward Ye
|
| |
|
Acting Chief Financial Officer
|
| |
|
(Principal Accounting Officer)
|
